Rigel Pharmaceuticals RIGL is scheduled to report third-quarter 2025 results on Nov. 4, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at $61.6 ...
8don MSN
Jim Cramer blesses Rigel Pharmaceuticals as a spec as “it’s doing better than people realize”
Jim Cramer reviewed Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) while breaking down 16 stocks for a market facing higher energy ...
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2026-03-03. Here's what investors need to know before the announcement. Analysts estimate that Rigel ...
Dose expansion phase will determine the recommended Phase 2 dose of R289 for patients with transfusion dependent R/R lower-risk MDS SOUTH SAN FRANCISCO, Calif., Oct. 8, 2025 /PRNewswire/ -- Rigel ...
SOUTH SAN FRANCISCO, Calif., Oct. 3, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, ...
Rigel Pharmaceuticals (NASDAQ:RIGL) is gearing up to announce its quarterly earnings on Tuesday, 2025-11-04. Here's a quick overview of what investors should know before the release. Analysts are ...
Have you been paying attention to shares of Rigel Pharmaceuticals (RIGL)? Shares have been on the move with the stock up 73.3% over the past month. The stock hit a new 52-week high of $51.73 in the ...
Shares of Rigel Pharmaceuticals (RIGL) have been strong performers lately, with the stock up 56.6% over the past month. The stock hit a new 52-week high of $30.43 in the previous session. Rigel has ...
The MarketWatch News Department was not involved in the creation of this content. SOUTH SAN FRANCISCO, Calif., Jan. 9, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results